Ilya Iofin, MD Email Ilya Iofin
-
- Position
- ASSISTANT PROFESSOR | Orthopedics
-
- Specialty
- Orthopedics & Orthopedic Surgery
-
- Languages
- English
- Russian
- German
- Spanish
- Serbo-Croatian
-
- Hospital Affiliations
- Mount Sinai Beth Israel
- The Mount Sinai Hospital
- Mount Sinai Morningside and Mount Sinai West
-
- Phone
- FPA/Department of Orthopedics 212-241-0786 212-241-0786
- Physical Medicine and Rehabilitation 212-241-0786 212-241-0786
- Mount Sinai Doctors - Scarsdale 212-241-0786 212-241-0786
Dr. Ilya Iofin is the Chief of Orthopaedic Oncology Service at Mount Sinai Hospital. He received his undergraduate degree from Princeton University and his medical degree from WashingtonUniversity School of Medicine. He completed residency in orthopaedic surgery at NYU Hospital for Joint Diseases. His fellowship training in orthopaedic oncology was done at the Washington Hospital Center/Georgetown University.
Dr. Iofin specializes in the treatment of benign and malignant tumors of bone and soft tissue in patients of all ages. The treatment ranges from minimally invasive procedures to extensive limb sparing surgeries. The care of each patient involves a multidisciplinary team approach. Dr. Iofin works closely with musculoskeletal radiologists, pathologists, medical and radiation oncologists to provide the best medical care.
In the News: Dr. Ilya Iofin discusses cancer research in The Daily News feature The Daily Check Up.
Certification
American Board of Orthopaedic Surgery
Clinical Focus
- Bone Cancer
- Chondrosarcoma
- Hemangioma
- Hip joint replacement
- Knee Replacement
- Lipoma
- Open Reduction And Internal Fixation Surgery
- Osteochondroma
- Sarcoma
- Soft Tissue Sarcoma
Education
MD, Washington University Medical Center
Residency, Orthopaedic Surgery
Hospital For Joint Diseases
Fellowship, Orthopaedic Oncology
Washington Hospital Center
Languages
English, Russian, German, Spanish, Serbo-Croatian
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr.Iofin did not report having any of the following types of financial relationships with industry during 2020 and/or 2021: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website.
Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.